BURLINGTON, N.C.–Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announces that it will be the first national clinical laboratory to offer HBV PCR testing using a newly FDA approved assay, the Roche COBAS® TaqMan® HBV Test. This assay, to be offered next week, is intended to be used as an aid in managing patients with […]
Signature Genomic Laboratories announced the release of an enhanced microarray for the prenatal detection of chromosome abnormalities that result in missing or extra pieces of DNA. The first tier of Signature’s Prenatal Service, the enhanced PrenatalChip(R) targets over 100 discrete chromosomal regions, the gain or loss of which results in a genetic disorder, while minimizing […]
BioCurex Inc. (OTCBB: BOCX) has incorporated a fully-owned subsidiary, BioCurex China, in Shanghai. This followed a lengthy legal process – required of all foreign companies – that took several months to complete. The subsidiary will initially operate as a clinical laboratory for RECAF testing and will serve both local hospitals and physicians. This expansion is […]
Celera Corporation (NASDAQ:CRA) today announced that it has entered into a research collaboration with Abbott to identify genetic markers for one of Abbott’s investigational compounds. A key aim of the collaboration is to investigate if genetic variants Celera has identified can predict how patients may respond to treatment. The identification of treatment response markers may […]
American College of Preventive Medicine (ACPM) and Navigenics, Inc. today announced a medical education program designed to improve physicians’ understanding of genetic risk factors for disease, the current evidence about the use of genomic tools and technologies to determine risk, and promising practices for utilizing those tools to aid in disease prevention. Through an unrestricted […]
London, UK, 4 November 2008 – Smiths Detection today announces that it is developing a rapid diagnostic system, initially for use in hospital screening programmes for infectious diseases such as MRSA and Clostridium difficile. The Bio-Seeq system will provide easy-to-use tests suitable for either a laboratory or Point of Care setting where it can be […]
Osmetech plc (LSE:OMH), the international molecular diagnostics company announces the launch of a genetic test for CYP450 2C9 drug metabolism. CYP450 2C9, or CYP2C9, is an important member of the Cytochrome P450 family of enzymes responsible for detoxifying potentially hazardous chemicals, such as drugs, that are “foreign” to the body. The CYP2C9 gene is important […]
Fourth ‘Moderate Complexity’ Categorization Highlights GeneXpert(R) System Ease-of-Use SUNNYVALE, Calif., Nov. 4 — Cepheid (Nasdaq: CPHD – News) today announced the U.S. Food & Drug Administration (FDA) categorized Cepheid’s Xpert(TM) MRSA/SA Blood Culture (BC) test as “Moderate Complexity” under the Clinical Laboratory Improvement Amendments (CLIA). The new test is designed for on-demand detection of Methicillin-resistant […]
Celera (NASDAQ:CRA) today announced the appointment of Scott K. Milsten as Vice President, General Counsel and Corporate Secretary, effective immediately. Mr. Milsten will report to Kathy Ordonez, Celera’s Chief Executive Officer. Mr. Milsten was most recently Deputy General Counsel for Gen-Probe Incorporated (NASDAQ:GPRO). In this capacity, he managed corporate governance and securities compliance, and structured […]
Source MDx today announced a partnership with Brigham and Women’s Hospital in Boston to examine RNA-based biomarkers in multiple sclerosis (MS) patients and healthy control participants unaffected by the disease. The goal of the study is to identify diagnostic markers and to determine markers of active disease (relapses) or stable disease, along with response markers […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
